Quick Answer
Rallybio Corp reported Total Assets of $62.26 million for fiscal year 2025.
Rallybio Corp Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $62.26M | -8.6% |
| 2024 | $68.11M | -41.1% |
| 2023 | $115.62M | -35.9% |
| 2022 | $180.44M | -1.0% |
| 2021 | $182.19M | +28.4% |
| 2020 | $141.86M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $67.66M | -14.4% | +32.7% |
| June 30, 2025 | $51.00M | -44.8% | -12.0% |
| March 31, 2025 | $57.98M | -41.6% | -14.9% |
| December 31, 2024 | $68.11M | -41.1% | -13.8% |
| September 30, 2024 | $79.01M | -40.7% | -14.5% |
| June 30, 2024 | $92.43M | -37.4% | -7.0% |
| March 31, 2024 | $99.36M | -38.8% | -14.1% |
| December 31, 2023 | $115.62M | -35.9% | -13.2% |
- Rallybio Corp showed a decrease of -8.6% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Rallybio Corp’s total assets has declined by 56.1% (from $141.86 million to $62.26 million).
- The most recent figure is from Rallybio Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: